Altimmune Stock

Altimmune Net Margin

The Net Profit Margin of Altimmune (ALT) as of Jul 22, 2026 is -475,295.00 %. In the previous year, Net Profit Margin was -20,762.21 % — a change of 2,189.23% (lower).

Net Margin

-475,295.00 %

YoY

2,189.23%

Last updated:

Net Profit Margin of Altimmune is 2026 -475,295.00 % . Net Profit Margin of Altimmune was 2025 -20,762.21 % . It decreases by 2,189.23% lower compared to the previous year.

For Altimmune, the net margin of -475,295.0% is down versus -598.8% a few years ago.

Access this data via the Eulerpool API

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

Net Profit Margin of Altimmune is -475,295.00 % in 2026.

Access this data via the Eulerpool API

Margins — Altimmune

All Key Metrics — Altimmune